|
Moderna attacks pivotal resistance - Analysis - 04-08-2022
Moderna's stock (MRNA) surged after maintaining sales directives for 2022 for its Covid 19 vaccine, even as deliveries decline, with results nonetheless beating estimates, with the stock surging 15.97%, or 25.68 points, and settling at 186.49, with trading volumes surpassing 13.7 million shares above 10-day averages of 4.3 million shares.
The upward correctional short-term wave dominates, buoyed by trading above 50-day SMA, with positive signals from the RSI, after reaching oversold levels, tackling the important resistance of 188.00.
Therefore we expect more gains for the stock, targeting the resistance of 233.50, provided the initial resistance of 188.00 was breached.
Expected trend for today: Bullish
Thanks for your feedback.
Midday update for the NZDUSD 04-08-2022
The NZDUSD pair reached our first target at 0.6320 now, waiting for more rise to breach this level and confirm extending the bullish wave towards 0.6380, reminding you that the continuation of the bullish wave depends on the price stability above 0.6257.
MoreMidday update for the AUDUSD 04-08-2022
The AUDUSD pair managed to touch our first waited target at 0.6980 and attempts to breach it, reinforcing the expectations of continuing the bullish wave and head to visit 0.7050 as a next target, to keep our bullish overview conditioned by the price stability above 0.6910.
MoreMidday update for Brent oil 04-08-2022
Brent oil price resumes its negative trading calmly to press on 100.00 barrier, waiting for more decline to confirm opening the way to head towards our next target at 95.90, to keep the bearish trend scenario active for today conditioned by the price stability below 102.25.
More